404. Deputy Michael Harty asked the Minister for Health his plans to intervene in the unprecedented High Court appeal brought by a company (details supplied) against the HSE decision not to reimburse for Translarna for the treatment of Duchenne muscular dystrophy in two persons in view of the fact that this legal process will be more costly than providing the drug and may result in these two persons missing their opportunity for treatment; and if he will make a statement on the matter. [44063/17]

Summary

404. Deputy Michael Harty asked the Minister for Health his plans to intervene in the unprecedented High Court appeal brought by a company (details supplied) against the HSE decision not to reimburse for Translarna for the treatment of Duchenne muscular dystrophy in two persons in view of the fact that this legal process will be more costly than providing the drug and may result in these two persons missing their opportunity for treatment; and if he will make a statement on the matter. [44063/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 17 October 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.